2.81BUSD
Type
Common Stock
Exchange
PINK
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US04530Y1064
CUSIP
04530Y106
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
June
IPO date
-
Updated At
-
PE Ratio
11.60
PEG Ratio
-
Book Value
191.59
Dividend Share
3.59
Dividend Yield
3.28%
Earnings Share
0.55
Wall Street Target Price
-
EPS Estimate Current Year
-
EPS Estimate Next Year
-
EPS Estimate Current Quarter
0
EPS Estimate Next Quarter
0
Most Recent Quarter
-
Revenue TTM
45,525,000,192
Gross Profit TTM
20,558,000,128
EBITDA
10,791,999,488
Profit Margin
9.84%
Return On Assets TTM
4.21%
Return On Equity TTM
5.25%
Revenue Per Share TTM
102.511
Qtly Revenue Growth YOY
3.90%
Diluted Eps TTM
0.55
Qtly Earnings Growth YOY
3.20%
Trailing PE
11.60
Forward PE
0
Price Sales TTM
0.0623
Price Book MRQ
0.6147
Enterprise Value Revenue
1
Enterprise Value EBITDA
10
138.65
4.10%42.37
3.39%111.00
2.68%153.47
0.80%13.80
0.51%32.13
0.00%10.18
-1.12%27.57
-0.97%15.04
-0.56%14.70
-0.03%